Maintenance therapy with subcutaneous imsidolimab allowed all treated patients to remain flare-free throughout the GEMINI-2 study period.

Feb 18 (Reuters) - Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ...

Why aren't we talking about it more?

A gel-like sugar coating on immune cells has been found to play a starring role in psoriasis. Researchers discovered that immune cells shed this outer layer to help them exit the bloodstream and enter ...

An increase in the proportion of plant-based foods in the diet may be associated with a decrease in the severity of psoriasis symptoms. This conclusion was reached by researchers from King's College ...

People with psoriasis often describe an itchy sensation that burns and is painful. Most people with psoriasis experience itchiness, but there are ways to manage this symptom. People with psoriasis ...

Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...

Evidence from multiple trials links weight loss with milder symptoms and improved wellbeing in people with psoriasis.

Psoriasis causes your body to make new skin cells too quickly. These cells tend to pile up and form spots, bumps, and thick scaly patches called plaques that can be uncomfortable. Scientists think ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

Patients with psoriasis were associated with significantly lower circulating BDNF levels compared with healthy control individuals.